T-Cell Depleted Allogeneic HSCT for Patients with Relapsed, High-Risk Multiple Myeloma Permits Long-Lasting Remissions in the Absence of Graft-Versus-Host Disease and Provides a Platform for Adoptive Immunotherapeutic Approaches

Guenther Koehne; Sean Devlin; Heather Landau; Hani Hassoun; Alexander M. Lesokhin; Nikoletta Lendvai; David J. Chung; Christina Bravo; Sergio A. Giralt

doi:10.1016/j.bbmt.2013.12.028

T-Cell Depleted Allogeneic HSCT for Patients with Relapsed, High-Risk Multiple Myeloma Permits Long-Lasting Remissions in the Absence of Graft-Versus-Host Disease and Provides a Platform for Adoptive Immunotherapeutic Approaches

Guenther Koehne, Sean Devlin, Heather Landau, Hani Hassoun, Alexander M. Lesokhin, Nikoletta Lendvai, David J. Chung, Christina Bravo, Sergio A. Giralt

Miami Cancer Institute

Research output: Contribution to conference › Presentation

Original language	American English
DOIs	https://doi.org/10.1016/j.bbmt.2013.12.028
State	Published - Jan 2 2014
Event	Biology of Blood and Marrow Transplantation - Duration: Jan 1 2020 → …

Conference

Conference	Biology of Blood and Marrow Transplantation
Period	1/1/20 → …

Disciplines

Medicine and Health Sciences
Immunology and Infectious Disease

Access to Document

10.1016/j.bbmt.2013.12.028License: Unspecified

Cite this

Koehne, G., Devlin, S., Landau, H., Hassoun, H., Lesokhin, A. M., Lendvai, N., Chung, D. J., Bravo, C., & Giralt, S. A. (2014). T-Cell Depleted Allogeneic HSCT for Patients with Relapsed, High-Risk Multiple Myeloma Permits Long-Lasting Remissions in the Absence of Graft-Versus-Host Disease and Provides a Platform for Adoptive Immunotherapeutic Approaches. Biology of Blood and Marrow Transplantation. https://doi.org/10.1016/j.bbmt.2013.12.028

T-Cell Depleted Allogeneic HSCT for Patients with Relapsed, High-Risk Multiple Myeloma Permits Long-Lasting Remissions in the Absence of Graft-Versus-Host Disease and Provides a Platform for Adoptive Immunotherapeutic Approaches. / Koehne, Guenther; Devlin, Sean; Landau, Heather et al.
2014. Biology of Blood and Marrow Transplantation.

Research output: Contribution to conference › Presentation

Koehne, G, Devlin, S, Landau, H, Hassoun, H, Lesokhin, AM, Lendvai, N, Chung, DJ, Bravo, C & Giralt, SA 2014, 'T-Cell Depleted Allogeneic HSCT for Patients with Relapsed, High-Risk Multiple Myeloma Permits Long-Lasting Remissions in the Absence of Graft-Versus-Host Disease and Provides a Platform for Adoptive Immunotherapeutic Approaches', Biology of Blood and Marrow Transplantation, 1/1/20. https://doi.org/10.1016/j.bbmt.2013.12.028

Koehne G, Devlin S, Landau H, Hassoun H, Lesokhin AM, Lendvai N et al.. T-Cell Depleted Allogeneic HSCT for Patients with Relapsed, High-Risk Multiple Myeloma Permits Long-Lasting Remissions in the Absence of Graft-Versus-Host Disease and Provides a Platform for Adoptive Immunotherapeutic Approaches. 2014. Biology of Blood and Marrow Transplantation. doi: 10.1016/j.bbmt.2013.12.028

@conference{9d06b89bfa304cfc92e70619a0701cd7,

title = "T-Cell Depleted Allogeneic HSCT for Patients with Relapsed, High-Risk Multiple Myeloma Permits Long-Lasting Remissions in the Absence of Graft-Versus-Host Disease and Provides a Platform for Adoptive Immunotherapeutic Approaches",

author = "Guenther Koehne and Sean Devlin and Heather Landau and Hani Hassoun and Lesokhin, \{Alexander M.\} and Nikoletta Lendvai and Chung, \{David J.\} and Christina Bravo and Giralt, \{Sergio A.\}",

year = "2014",

month = jan,

day = "2",

doi = "10.1016/j.bbmt.2013.12.028",

language = "American English",

note = "Biology of Blood and Marrow Transplantation ; Conference date: 01-01-2020",

}

TY - CONF

T1 - T-Cell Depleted Allogeneic HSCT for Patients with Relapsed, High-Risk Multiple Myeloma Permits Long-Lasting Remissions in the Absence of Graft-Versus-Host Disease and Provides a Platform for Adoptive Immunotherapeutic Approaches

AU - Koehne, Guenther

AU - Devlin, Sean

AU - Landau, Heather

AU - Hassoun, Hani

AU - Lesokhin, Alexander M.

AU - Lendvai, Nikoletta

AU - Chung, David J.

AU - Bravo, Christina

AU - Giralt, Sergio A.

PY - 2014/1/2

Y1 - 2014/1/2

UR - http://www.bbmt.org/article/S1083-8791(13)00599-5/fulltext

U2 - 10.1016/j.bbmt.2013.12.028

DO - 10.1016/j.bbmt.2013.12.028

M3 - Presentation

T2 - Biology of Blood and Marrow Transplantation

Y2 - 1 January 2020

ER -

T-Cell Depleted Allogeneic HSCT for Patients with Relapsed, High-Risk Multiple Myeloma Permits Long-Lasting Remissions in the Absence of Graft-Versus-Host Disease and Provides a Platform for Adoptive Immunotherapeutic Approaches

Conference

Disciplines

Access to Document

Other files and links

Cite this